位元堂(00897)发布中期业绩，股东应占溢利277.2万港元 同比减少88.3%

Core Insights - The company reported a revenue of approximately HKD 323 million for the six months ending September 30, 2025, representing a year-on-year decrease of 6.93% [1] - The profit attributable to the parent company was HKD 2.772 million, a significant decline of 88.3% compared to HKD 23.701 million in the same period last year [1] - Earnings per share were reported at HKD 0.025 [1] Revenue Performance - The decrease in revenue is primarily attributed to weakened sales performance in traditional Chinese medicine, Western medicine, and health food products [1]